134 related articles for article (PubMed ID: 36634852)
21. Interobserver variability in gross tumor volume contouring in non-spine bone metastases.
de la Pinta C; LaTorre RG; Martínez-Lorca A; Fernández E; Hernanz R; Martín M; Domínguez JA; Muñóz T; Canales E; Vallejo C; Alarza M; Hervás A; Garví M; Pino V; Sancho S
J Clin Transl Res; 2022 Dec; 8(6):465-469. PubMed ID: 36452000
[TBL] [Abstract][Full Text] [Related]
22. Variability of gross tumour volume delineation: MRI and CT based tumour and lymph node delineation for lung radiotherapy.
Kumar S; Holloway L; Boxer M; Yap ML; Chlap P; Moses D; Vinod S
Radiother Oncol; 2022 Feb; 167():292-299. PubMed ID: 34896156
[TBL] [Abstract][Full Text] [Related]
23. Cone-beam CT-based delineation of stereotactic lung targets: the influence of image modality and target size on interobserver variability.
Altorjai G; Fotina I; Lütgendorf-Caucig C; Stock M; Pötter R; Georg D; Dieckmann K
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e265-72. PubMed ID: 21620581
[TBL] [Abstract][Full Text] [Related]
24. NaF PET/CT for response assessment of prostate cancer bone metastases treated with single fraction stereotactic ablative body radiotherapy.
Hardcastle N; Hofman MS; Lee CY; Callahan J; Selbie L; Foroudi F; Shaw M; Chander S; Lim A; Chesson B; Murphy DG; Kron T; Siva S
Radiat Oncol; 2019 Sep; 14(1):164. PubMed ID: 31488175
[TBL] [Abstract][Full Text] [Related]
25. Volumetric and dosimetric impact of MRI in delineation of gross tumor volume of non-spinal vertebral metastases treated with stereotactic ablative radiation therapy.
Ilamurugu A; Chandrasekaran A; Ayyalusamy A; Prasanna Satpathy S; Reddy JM; Arora S; Subramanian S; Velayudham R
Cancer Radiother; 2021 Apr; 25(2):135-140. PubMed ID: 33422419
[TBL] [Abstract][Full Text] [Related]
26. Target volume delineation for preoperative radiotherapy of rectal cancer: inter-observer variability and potential impact of FDG-PET/CT imaging.
Krengli M; Cannillo B; Turri L; Bagnasacco P; Berretta L; Ferrara T; Galliano M; Gribaudo S; Melano A; Munoz F; Sciacero P; Tseroni V; Bassi MC; Brambilla M; Inglese E
Technol Cancer Res Treat; 2010 Aug; 9(4):393-8. PubMed ID: 20626204
[TBL] [Abstract][Full Text] [Related]
27. Investigation of the clinical inter-observer bias in prostate fiducial marker image registration between CT and MR images.
Persson E; Emin S; Scherman J; Jamtheim Gustafsson C; Brynolfsson P; Ceberg S; Gunnlaugsson A; Olsson LE
Radiat Oncol; 2021 Aug; 16(1):150. PubMed ID: 34399806
[TBL] [Abstract][Full Text] [Related]
28. Prostate post-implant dosimetry: interobserver variability in seed localisation, contouring and fusion.
De Brabandere M; Hoskin P; Haustermans K; Van den Heuvel F; Siebert FA
Radiother Oncol; 2012 Aug; 104(2):192-8. PubMed ID: 22857857
[TBL] [Abstract][Full Text] [Related]
29. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
Kosztyla R; Chan EK; Hsu F; Wilson D; Ma R; Cheung A; Zhang S; Moiseenko V; Benard F; Nichol A
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1100-6. PubMed ID: 24161427
[TBL] [Abstract][Full Text] [Related]
30. Variability of radiotherapy volume delineation: PSMA PET/MRI and MRI based clinical target volume and lymph node target volume for high-risk prostate cancer.
Liu LL; Zhu LL; Lu ZG; Sun JD; Zhao J; Wang HF; Xiang ZL
Cancer Imaging; 2023 Jan; 23(1):1. PubMed ID: 36600283
[TBL] [Abstract][Full Text] [Related]
31. ESTRO ACROP consensus guideline on CT- and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer.
Salembier C; Villeirs G; De Bari B; Hoskin P; Pieters BR; Van Vulpen M; Khoo V; Henry A; Bossi A; De Meerleer G; Fonteyne V
Radiother Oncol; 2018 Apr; 127(1):49-61. PubMed ID: 29496279
[TBL] [Abstract][Full Text] [Related]
32. Evaluating diffusion-weighted magnetic resonance imaging for target volume delineation in head and neck radiotherapy.
Cardoso M; Min M; Jameson M; Tang S; Rumley C; Fowler A; Estall V; Pogson E; Holloway L; Forstner D
J Med Imaging Radiat Oncol; 2019 Jun; 63(3):399-407. PubMed ID: 30816646
[TBL] [Abstract][Full Text] [Related]
33. Magnetic resonance imaging- versus computed tomography-based target volume delineation of the glandular breast tissue (clinical target volume breast) in breast-conserving therapy: an exploratory study.
Giezen M; Kouwenhoven E; Scholten AN; Coerkamp EG; Heijenbrok M; Jansen WP; Mast ME; Petoukhova AL; Struikmans H
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):804-11. PubMed ID: 20843611
[TBL] [Abstract][Full Text] [Related]
34. Radiotherapy treatment planning: benefits of CT-MR image registration and fusion in tumor volume delineation.
Djan I; Petrović B; Erak M; Nikolić I; Lucić S
Vojnosanit Pregl; 2013 Aug; 70(8):735-9. PubMed ID: 24069821
[TBL] [Abstract][Full Text] [Related]
35. Inter- and intra-observer variability in contouring of the prostate gland on planning computed tomography and cone beam computed tomography.
Choi HJ; Kim YS; Lee SH; Lee YS; Park G; Jung JH; Cho BC; Park SH; Ahn H; Kim CS; Yi SY; Ahn SD
Acta Oncol; 2011 May; 50(4):539-46. PubMed ID: 21391773
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of high dose volumetric CT to reduce inter-observer delineation variability and PTV margins for prostate cancer radiotherapy.
Alasti H; Cho YB; Catton C; Berlin A; Chung P; Bayley A; Vandermeer A; Kong V; Jaffray D
Radiother Oncol; 2017 Oct; 125(1):118-123. PubMed ID: 28859933
[TBL] [Abstract][Full Text] [Related]
37. Definition of the prostate in CT and MRI: a multi-observer study.
Rasch C; Barillot I; Remeijer P; Touw A; van Herk M; Lebesque JV
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):57-66. PubMed ID: 9989514
[TBL] [Abstract][Full Text] [Related]
38. Magnetic resonance imaging in postprostatectomy radiotherapy planning.
Sefrova J; Odrazka K; Paluska P; Belobradek Z; Brodak M; Dolezel M; Prosvic P; Macingova Z; Vosmik M; Hoffmann P; Louda M; Nejedla A
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):911-8. PubMed ID: 21420244
[TBL] [Abstract][Full Text] [Related]
39. Addition of MRI for CT-based pancreatic tumor delineation: a feasibility study.
Gurney-Champion OJ; Versteijne E; van der Horst A; Lens E; Rütten H; Heerkens HD; Paardekooper GMRM; Berbee M; Rasch CRN; Stoker J; Engelbrecht MRW; van Herk M; Nederveen AJ; Klaassen R; van Laarhoven HWM; van Tienhoven G; Bel A
Acta Oncol; 2017 Jul; 56(7):923-930. PubMed ID: 28375667
[TBL] [Abstract][Full Text] [Related]
40. GTV delineation in supraglottic laryngeal carcinoma: interobserver agreement of CT versus CT-MR delineation.
Jager EA; Kasperts N; Caldas-Magalhaes J; Philippens ME; Pameijer FA; Terhaard CH; Raaijmakers CP
Radiat Oncol; 2015 Jan; 10():26. PubMed ID: 25612508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
